TLSI
TLSI
NASDAQ · Biotechnology

Trisalus Life Sciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$4.55
-0.19 (-4.01%)
As of Jun 30, 10:23 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target -4.8% upside
Low Target $2.61
Average Target $4.33
High Target $5.56
Current Price $4.55
Current
$4.55
Target
$4.33
$2.61 $4.33 avg $5.56
Scenario Analysis
Bear Case
$2.61
-42.6%
Low target
Base Case
$4.33
-4.8%
Avg target
Bull Case
$5.56
+22.2%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$7.95
-42.8% from high
52-Week Low
$2.20
+106.8% from low
Target vs 52W High
$4.33
-45.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%